Skip to content
Linkedin Twitter

COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
  • Checkout
  • Order Confirmation
  • Order Failed
Menu
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
  • Checkout
  • Order Confirmation
  • Order Failed
COVID-19 Briefings

Free COVID-19 STAT Intelligence Briefings Email Digest

Subscribe Now!
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
  • Checkout
  • Order Confirmation
  • Order Failed
Menu
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
  • Checkout
  • Order Confirmation
  • Order Failed
Linkedin Twitter

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

Day: June 5, 2020

Lack of Coherent Testing Strategy Creates Uncertainties for Clinical Laboratories about COVID-19 Testing Volumes

national-testing-strategy-SARS-CoV-2-coalition

Influential quotes by Gary Procop, MD, MS, of the Cleveland Clinic, on the role of clinical laboratory and anatomic pathology group leaders in developing a national COVID-19 testing strategy.

Clinical Laboratories May Lose SARS-CoV-2 Testing Volumes to Veterinarian Labs

vet-vs-human-testing-covid19

Implications of blurring the lines between human testing laboratories and veterinarian labs.

HHS Announces New Guidance for SARS-CoV-2 Testing Reporting by Clinical Laboratories

Requirements around COVID-19 testing

SARS-CoV-2 test reporting requirements just multiplied. Clinical laboratories are on a deadline now.

FDA Issues List of SARS-CoV-2 Antibody Tests That Have Been Removed from the FDA’s Notification List

FDA-serology-test-removed-not-for-distribution

Introduction to commercially manufactured SARS-CoV-2 serology tests listed with the status of “Removed – Should Not Be Distributed.”

More COVID-19 Coverage Can Be Found in THE DARK REPORT
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
  • Checkout
  • Order Confirmation
  • Order Failed
Menu
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
  • Checkout
  • Order Confirmation
  • Order Failed

Copyright 2020 © The Dark Report. All rights reserved. The Dark Intelligence Group • 21806 Briarcliff Dr • Spicewood, TX 78669

  • Phone: 512-264-7103
Linkedin Twitter